JASON  HOU  to  Veterans
                            
                            
                                This is a "connection" page, showing publications  JASON  HOU  has written about  Veterans.
                            
                            
                            
                                
                                    
                                            
    
        
        
        
            Connection Strength
            
                
            
            1.579
         
        
        
     
 
    
        
        - 
            Re: Lin I, Melsheimer R, Bhak RH, et al. Impact of switching to infliximab biosimilars on treatment patterns among US veterans receiving innovator infliximab. Curr Med Res Opin. 2022;38(4):613-627. Curr Med Res Opin. 2022 12; 38(12):2241-2242.
            
            
                Score: 0.346
             
- 
            Fragmentation, Care Models, and Improving Outcomes in Inflammatory Bowel Disease. JAMA Netw Open. 2020 09 01; 3(9):e2016122.
            
            
                Score: 0.302
             
- 
            The Incidence and Prevalence of Anxiety, Depression, and Post-traumatic Stress Disorder in a National Cohort of US Veterans With Inflammatory Bowel Disease. Inflamm Bowel Dis. 2020 08 20; 26(9):1423-1428.
            
            
                Score: 0.301
             
- 
            Assessment of disease specific knowledge and health-related quality of life among United States military veterans with inflammatory bowel disease. World J Gastroenterol. 2015 May 21; 21(19):6001-7.
            
            
                Score: 0.209
             
- 
            The incidence and prevalence of inflammatory bowel disease among U.S. veterans: a national cohort study. Inflamm Bowel Dis. 2013 Apr; 19(5):1059-64.
            
            
                Score: 0.180
             
- 
            Prevalence of Advanced Colorectal Neoplasia in Veterans: Effects of Age, Sex, and Race/Ethnicity. J Clin Gastroenterol. 2021 Nov-Dec 01; 55(10):876-883.
            
            
                Score: 0.082
             
- 
            Incidence of and Predictors for Early Discontinuation of Biological Therapies in Veteran Patients with Inflammatory Bowel Disease. Inflamm Bowel Dis. 2017 08; 23(8):1434-1439.
            
            
                Score: 0.061
             
- 
            Myelosuppression monitoring after immunomodulator initiation in veterans with inflammatory bowel disease: a national practice audit. Aliment Pharmacol Ther. 2012 Dec; 36(11-12):1049-56.
            
            
                Score: 0.044
             
- 
            Risk of colorectal cancer among Caucasian and African American veterans with ulcerative colitis. Inflamm Bowel Dis. 2012 Jun; 18(6):1011-7.
            
            
                Score: 0.040
             
- 
            Age Disparities in the Use of Steroid-sparing Therapy for Inflammatory Bowel Disease. Inflamm Bowel Dis. 2016 08; 22(8):1923-8.
            
            
                Score: 0.014